Virologic and immunologic efficacy of the tenofovir/didanosine/lamivudine regimen.
Quercia
Romina
R
Amiel
Corinne
C
Marechal
Elisete Da Silva
Eda S
Lebrette
Marie-Gisèle
MG
Thevenet
Sandrine
S
Renaud
Stéphanie
S
Schneider
Véronique
V
Kara
Ali
A
Guessant
Sabine
S
Pialoux
Gilles
G
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use*; D063065:Organophosphonates / Q000008:administration & dosage / Q000627:therapeutic use*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000068698:Tenofovir
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D000068698:Tenofovir; D000225:Adenine; D016049:Didanosine